Nevertheless, some studies have already shown that monoclonal antibodies against IL1RAP, the coreceptor of IL-1R1, suppress the proliferation of leukemic stem cells (LSCs) in AML [28,95] and CML models [27]. Here, IL1R1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.